The Antidiabetic Drug Lobeglitazone Protects Mice From Lipogenesis-Induced Liver Injury via Mechanistic Target of Rapamycin Complex 1 Inhibition
about
The Antidiabetic Drug Lobeglitazone Protects Mice From Lipogenesis-Induced Liver Injury via Mechanistic Target of Rapamycin Complex 1 Inhibition
description
scientific article published on 21 September 2018
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована у 2018
@uk
name
The Antidiabetic Drug Lobeglit ...... Rapamycin Complex 1 Inhibition
@en
The Antidiabetic Drug Lobeglit ...... Rapamycin Complex 1 Inhibition
@nl
type
label
The Antidiabetic Drug Lobeglit ...... Rapamycin Complex 1 Inhibition
@en
The Antidiabetic Drug Lobeglit ...... Rapamycin Complex 1 Inhibition
@nl
prefLabel
The Antidiabetic Drug Lobeglit ...... Rapamycin Complex 1 Inhibition
@en
The Antidiabetic Drug Lobeglit ...... Rapamycin Complex 1 Inhibition
@nl
P2093
P2860
P356
P1476
The Antidiabetic Drug Lobeglit ...... Rapamycin Complex 1 Inhibition
@en
P2093
Byung-Wan Lee
Da Hyun Lee
Dong-Kyu Lee
Jeong Su Park
Sung Won Kwon
Yu Seol Lee
P2860
P356
10.3389/FENDO.2018.00539
P407
P50
P577
2018-09-21T00:00:00Z